Showing 1141-1150 of 9359 results for "".
- Frost & Sullivan Commends Sensus for the Development of SRT-100™ and SRT-100 Vision™, its Low-energy Radiation Therapy Systems for Treating Skin Cancerhttps://practicaldermatology.com/news/20140331-frost__sullivan_commends_sensus_for_the_development_of_srt-100_and_srt-100_vision_its_low-energy_radiation_therapy_systems_for_treating_skin_cancer/2459289/Based on its recent analysis of the non-melanoma skin cancer therapy market, Frost & Sullivan recognizes Sensus Healthcare LLC with the 2014 North American Frost & Sullivan Award for New Product Innovation Leadership. Sensus uses a technique known as superficial radiation therapy (SRT) in its two l…
- Pierre Fabre Obtains FDA Approval to Market Hemangeol for the Treatment of Infantile Hemangiomahttps://practicaldermatology.com/news/20140319-pierre_fabre_obtains_fda_approval_to_market_hemangeol_for_the_treatment_of_infantile_hemangioma/2459311/Pierre Fabre Dermatologie has obtained marketing authorization from the FDA for the pediatric drug Hemangeol (propranolol hydrochloride), which is the first and only approved treatment for “proliferating infantile hemangioma requiring systemic therapy”. Hemangeol is an oral solution specially devel…
- Celebrity Who Has It? App and IMMUDYNE Have Combined for New Skincare Linehttps://practicaldermatology.com/news/20140314-celebrity_who_has_it_app_and_immudyne_have_combined_for_new_skincare_line/2459317/IMMUDYNE is partnering with Who Has It? App to promote the Company's skincare line, NAYAD Rejuvenating Serum and Moisturizer. NAYAD is a topical solution that naturally activates topical and circulatory immune system cells. "We believe that partnering with Jennifer Colli, her clients, and the Who…
- Kerecis Receives US Patent for Fish-Skin-Based Tissue Regeneration Technologyhttps://practicaldermatology.com/news/20140219-kerecis_receives_us_patent_for_fish-skin-based_tissue_regeneration_technology/2459340/A US patent was awarded to Kerecis Limited for the use of fish skin in medical applications. The Kerecis material consists of sheets of intact, decellularized fish skin that have had all cells and antigenic materials removed. Fish skin is largely made from the same material as human skin, with the …
- Probiotics Show Potential as Treatment for Acne and Rosaceahttps://practicaldermatology.com/news/20140210-probiotics_show_potential_as_treatment_for_acne_and_rosacea/2459345/Skin prone to acne or rosacea has shown improvement with daily probiotic use in recent research, giving dermatologists reason to consider supplementing traditional acne therapy with a dose of probiotics, according to a new release from the American Academy of Dermatology (AAD)…
- Valeant Pharmaceuticals Completes Acquisition of Solta Medicalhttps://practicaldermatology.com/news/20140127-valeant_pharmaceuticals_completes_acquisition_of_solta_medical/2459359/Valeant Pharmaceuticals International, Inc. completed its acquisition of Solta Medical, Inc. at a price of $2.92 per share in cash, or approximately $250 million in the aggregate. On January 23, 2014, Valeant successfully completed the tender offer for all outstanding shares …
- Alma Lasers Debuts its 2014 Webinar Serieshttps://practicaldermatology.com/news/20140116-alma_lasers_debuts_its_2014_webinar_series/2459372/In a complimentary webinar series, industry experts will showcase their success building local market awareness to drive practice results. Spearheaded by Alma Lasers , the informative sessions will include in-depth case studies direct from aesthetic professionals who've used Alma's proven marketing…
- Cutera Appoints Scott Ashworth as Executive Vice President of Global Saleshttps://practicaldermatology.com/news/20131230-cutera_appoints_scott_ashworth_as_executive_vice_president_of_global_sales/2459385/Scott Ashworth recently joined Cutera as Executive Vice President of Global Sales. He brings twenty-five years of experience in building and leading global sales and marketing teams focused on commercialization of products, establishing distribution partnerships, and other leadership roles in medic…
- Syneron's Home-Use Hair Removal Systems Receive Expanded Indicationhttps://practicaldermatology.com/news/20131219-synerons_home-use_hair_removal_systems_receive_expanded_indication/2459390/The FDA has granted Syneron Medical Ltd. and Iluminage Beauty an expanded indication for me™ brand of home-use hair removal systems. The systems, which utilize Syneron's proprietary elos technology, are now indicated for permanent reduction in hair growth. The me™ brand is owned and sold by Ilumina…
- Almirall S.A. to Aquire Aqua Pharmaceuticalshttps://practicaldermatology.com/news/20131217-almirall_sa_to_aquire_aqua_pharmaceuticals/2459392/RoundTable Healthcare Partners has entered into a definitive agreement to sell Aqua Pharmaceuticals Holdings, Inc. to Almirall S.A. for up to $402.6 million in cash. The consideration includes $327.6 million of cash at closing plus up to $75 million of contingent payments. Alm…